Elsunersen
Elsunersen (PRAX‑222) is a gapmer antisense oligonucleotide targeting SCN2A mRNA. Elsunersen reduces the protein level of the voltage-gated sodium channel NaV1.2 by degrading SCN2A mRNA, alleviating neuronal network hyperexcitability. Elsunersen combined with sodium channel blockers terminates refractory status epilepticus and reduces seizure frequency. Elsunersen can be used in research related to epileptic encephalopathy.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2756001-75-7
- Fòrmula: C230H320N67O126P19S13
- Peso molecular:7044.71
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas DNA/RNA Synthesis
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
Nav1.2 |
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Ensayo clínico
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 2756001-75-7
-
Peso molecular 7044.71
-
Fòrmula C230H320N67O126P19S13
-
SMILES
[Elsunersen]
-
Synonyms
PRAX-222
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)